Back to stories
Industry

Anthropic CFO Reveals Run Rate Tripled to $30B in a Single Quarter, Pegging $100B+ Compute Bet

Michael Ouroumis2 min read
Anthropic CFO Reveals Run Rate Tripled to $30B in a Single Quarter, Pegging $100B+ Compute Bet

Anthropic CFO Krishna Rao used his first-ever podcast appearance, on Patrick O'Shaughnessy's Invest Like the Best released May 13, to disclose that the company's annualized run-rate revenue jumped from roughly $9 billion at the start of 2026 to over $30 billion by the end of Q1 — a tripling in a single quarter. Rao joined Anthropic two years ago when run rate was about $250 million and has since helped raise approximately $75 billion in capital.

The numbers behind the jump

Rao framed Anthropic's growth around enterprise concentration rather than consumer reach. According to coverage of the podcast and subsequent analyses, nine of the Fortune 10 are now Claude customers, and the count of customers spending more than $1 million annually roughly doubled to around 1,000 in the two months following the company's February Series G. Net dollar retention is running above 500% annualized — extreme even by frontier-AI standards.

Internally, Rao said over 90% of Anthropic's own code is now written by Claude Code, which O'Shaughnessy and follow-up reporting have flagged as a leading indicator for how quickly the agentic-coding workload is consolidating against incumbents.

The $100B+ three-chip stool

The most operationally important disclosure was Anthropic's compute architecture. Rao described a deliberately diversified strategy across three vendors:

"If you buy too much compute, you go out of business. If you buy too little compute, you can't serve your customers," Rao said, calling compute "the lifeblood of our business" and the canvas on which everything else gets built. He estimated he spends 30 to 40% of his time on compute allocation decisions alone, with daily meetings rebalancing capacity between training, internal use, and customer-serving inference.

What this changes for builders

For enterprise buyers and infra teams, the disclosures are the clearest evidence yet that Claude's API capacity is being underwritten across three independent silicon roadmaps, lowering the chance of a single-vendor stall blocking SLAs. For competitors, the 500% net dollar retention and the Fortune 10 saturation rate strengthen the case that the enterprise-AI market is consolidating around a small number of frontier labs faster than the public valuation debate suggests. And for chip investors, the size of the compute commitments — well in excess of $100 billion across Amazon, Google/Broadcom and Nvidia — sets a floor under 2027 AI capex that few independent analysts had modeled before this week.

Learn AI for Free — FreeAcademy.ai

Take "AI for Business: Practical Implementation" — a free course with certificate to master the skills behind this story.

More in Industry

Google Ships Antigravity 2.0: A Standalone Agent Platform That Retires the Gemini CLI
Industry

Google Ships Antigravity 2.0: A Standalone Agent Platform That Retires the Gemini CLI

At I/O 2026, Google relaunched Antigravity as a standalone agent-orchestration platform with a CLI that replaces the Gemini CLI, an SDK, Managed Agents in the Gemini API, and an enterprise tier — all defaulting to Gemini 3.5 Flash.

10 min ago2 min read
Alibaba's Zhenwu M890 Claims 3x Nvidia's H20, Ships With Qwen 3.7-Max
Industry

Alibaba's Zhenwu M890 Claims 3x Nvidia's H20, Ships With Qwen 3.7-Max

Alibaba's chip unit T-Head unveiled the Zhenwu M890 AI accelerator, claiming 3x the agentic-inference performance of Nvidia's H20 and 144GB of HBM3, paired with the Qwen 3.7-Max model — a full domestic stack as US export controls tighten.

1 hours ago2 min read
Cohere Buys Reliant AI to Build 'North for Pharma' Sovereign Biopharma Agents
Industry

Cohere Buys Reliant AI to Build 'North for Pharma' Sovereign Biopharma Agents

Cohere has acquired Montréal- and Berlin-based biopharma startup Reliant AI, folding its automated research workbench into the North platform to launch 'North for Pharma' — its second acquisition in a month as it doubles down on sovereign, regulated-industry AI.

3 hours ago2 min read